Joely Irlam

Joely has more than 25 years of cancer research experience at the Christie Hospital and the University of Manchester, and she has 16 years of experience in developing, validating, and delivering hypoxia-associated biomarkers. She is a technical expert in clinical biomarker platform discovery, co-founding university spin-out company ManTRa Diagnostics Ltd, for which she also served as CEO, to deliver a genomic test for precision cancer treatments and improved patient outcomes. Joely is also involved in a steering group (Biomedical Research Engagement Academic clinical healthcare – BREACH) to encourage academic/industrial engagement, helping to drive academic science across the translational gap for cancer patient benefit.